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Invasion of enterocytes by Shigella flexneri requires the properly timed release of IpaB and IpaC at the
host-pathogen interface; however, only IpaC has been found to possess quantifiable activities in vitro. We
demonstrate here that when added to cultured cells, purified IpaC elicits cytoskeletal changes similar to those
that occur during Shigella invasion. This IpaC effect may correlate with its ability to interact with model
membranes at physiological pH and to promote entry by an ipaC mutant of S. flexneri.
Shigella flexneri is an important cause of dysentery with a
high incidence of infant mortality in developing nations. An
early step in Shigella infection is bacterial invasion of colonic
epithelial cells (8). Invasion is characterized by host cytoskel-
etal rearrangements at the site of bacterial contact, which leads
to the formation of filopodia that coalesce and trap the patho-
gen within a membrane-bound vacuole (1). The resulting pha-
gosomal membrane is rapidly lysed following pathogen uptake
(16). IpaB and IpaC have been identified as being the effectors
of Shigella invasion (9–11) following their secretion at the
host-pathogen interface via the mix-spa secretory system (4, 12,
21). Once released within this localized area, IpaB and IpaC
form a complex (2, 14) that is reported to be responsible for
pathogen entry (10, 12, 18, 20, 21).
It was originally proposed that IpaB alone induces bacterial
uptake and promotes the subsequent escape of S. flexneri into
the host cell cytoplasm (6). This role was revised when purified
IpaB could not be shown to possess membranolytic activity in
vitro (13) and when purified IpaC was found to possess both a
potential effector role in invasion (9, 19) and the ability to
cause the release of small molecules from phospholipid vesi-
cles at low pH (3). In the work presented here, a novel model
membrane system is used to show that purified IpaC pene-
trates phospholipid membranes at neutral pH and that this
activity may be correlated with IpaC’s role as an effector mol-
ecule that elicits cytoskeletal changes in cultured cells when it
is added to the extracellular environment. The ability for IpaC
to penetrate phospholipid membranes and to promote cellular
effects may provide a significant step forward in our under-
standing of the mechanism by which S. flexneri directs its own
uptake by enterocytes. Moreover, the data presented here may
have a broader impact in the area of bacterial pathogenesis
since Salmonella enterica initiates its entry into epithelial cells
by an outwardly similar mechanism that requires SipC, a pu-
tative IpaC homologue.
IpaC interacts with membranes at neutral pH. Protein pen-
etration of cell membranes occurs as a part of numerous bio-
logical processes. The incorporation of proteins into phospho-
lipid Langmuir monolayers (17) provides a potentially valuable
model for exploring specific protein-lipid interactions that have
an important role in the pathogenesis of S. flexneri. The Lang-
muir membrane system used here is composed of a dipalmi-
toyl-phosphatidylcholine (DPPC) monolayer generated on top
of a buffered aqueous subphase. This system mimics the outer
faces of the cytoplasmic membranes of most mammalian cell
types, as they are encountered by proteins secreted from S.
flexneri. Although such a monolayer is structurally different
from the phospholipid bilayer that makes up a cell’s cytoplas-
mic membrane, it provides a suitable model membrane for
sensitively detecting specific lipid-protein interactions such as
those that occur at the surface of a cell.
When a protein is injected into an aqueous subphase and
given time to interact with an overlying lipid monolayer,
changes in surface pressure can be monitored to deduce the
nature of the protein-lipid interaction. Penetration of a protein
into the phospholipid monolayer forces the phospholipids to
become more tightly packed due to the space taken up by the
protein (thereby giving rise to an increase in surface pressure).
While the phospholipid monolayer model used here does not
reproduce the entire structure of the cellular phospholipid
bilayer, it has been shown to provide an effective system for
monitoring protein-membrane interactions (17). Moreover,
the sensitivity for detecting protein penetration of membranes
using Langmuir monolayers far surpasses that seen using con-
ventional approaches that detect protein-membrane interac-
tions only after they result in the disruption of phospholipid
vesicles (3). Because IpaC-mediated effects on cultured cells
have not been found to be cytotoxic, it is important to explore
this protein’s interaction with model membranes under condi-
tions that, during invasion, may induce only subtle changes in
the structure of the cytoplasmic membrane.
For proteins that do not interact with phospholipid mem-
branes, maximum accumulation of the protein at the air-water
interface occurs in the absence of phospholipids or when the
phospholipids are very loosely packed and provide gaps at the
air-water interface for the proteins to occupy. The ability of
such a protein to accumulate at the air-water interface is rap-
idly diminished when the initial monolayer density is increased
until, at high initial lipid densities, the protein’s access to the
air-water interface is blocked (17). In contrast, a protein that
possesses the ability to penetrate a phospholipid membrane
tends to interact poorly at the air-water interface but demon-
strates an enhanced ability to migrate to this site as the initial
phospholipid monolayer density is increased. This behavior is
common for known membrane-penetrating proteins such as
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factor VII, a protein involved in the blood-clotting cascade
(17).
The ipaC coding sequence was cloned and expressed, and
IpaC was purified as described previously (15). The presence
of a short leader sequence containing a His6 tag allowed af-
finity purification of IpaC in the presence of 6 M urea (2).
When prepared with urea, IpaC was dialyzed against 20 mM
phosphate (pH 7.2)–150 mM NaCl (phosphate-buffered saline
[PBS]) containing 2 M urea. Refolding of the protein was
facilitated by rapid dilution as described previously (2), and
protein concentrations were measured by a bicinchoninic acid
protein assay (Sigma Chemical Co.). To monitor potential
interactions between purified recombinant IpaC and a DPPC
monolayer, a NIMA model 611D Langmuir-Blodgett trough
equipped with a model PS4 pressure sensor was used to mon-
itor changes in membrane surface pressure (17). An aqueous
subphase containing 0.1 M Tris (pH 7.4) was used, and in some
experiments, calcium chloride was added to a concentration of
10 mM. To form phospholipid monolayers, 100 ml of 1-mg/ml
DPPC prepared in chloroform was dropped onto the subphase
and the solvent was removed by evaporation. The monolayers
were then compressed to predetermined surface pressures.
Fibrinogen was used here as a negative-control protein that
does not interact with phospholipid membranes, and blood-
clotting factor VII was used as a positive-control protein
known to penetrate phospholipid membranes in a calcium-
dependent manner. Fibrinogen was prepared in 0.1 M Tris (pH
7.4), and 500 ml was injected into the subphase to give a final
concentration of 3 mg/ml. IpaC and factor VII (500 ml each)
were added to the subphase to give a final concentration of
0.02 mg/ml each. The proteins were allowed to interact with the
monolayer for 75 min, and the degree of protein accumulation
at the interfacial region was measured as a time-dependent
increase in surface pressure.
The largest changes in surface pressure for the negative-
control protein (fibrinogen) were observed at the lowest initial
lipid pressures (Fig. 1A), with no increase in surface pressure
seen when the monolayer was compressed to 10 mN/m or
higher. In contrast, IpaC showed the highest changes in surface
pressure at the highest initial lipid pressures (Fig. 1B), with no
surface activity seen in the absence of phospholipids. Mem-
brane-binding proteins typically display this type of increased
surface activity in the presence of a compacted phospholipid
monolayer (17). Even at initial surface pressures approaching
30 mN/m (the estimated average density of phospholipids in
the cell membrane), IpaC efficiently penetrated the DPPC
monolayer, although at a rate that was somewhat lower than
when the initial surface pressure was 15 mN/m (data not
shown), indicating that this activity has physiological relevance.
The magnitude of the increased surface pressure caused by
IpaC was comparable to that seen with the same concentration
of factor VII, which also displays an enhanced ability to pen-
etrate DPPC monolayers as the initial surface pressure is in-
creased (Table 1). These data indicate that IpaC interactions
with phospholipid membranes at neutral pH are similar to that
of a known membrane-penetrating protein. Unlike factor VII,
whose penetration of phospholipid membranes is calcium de-
pendent (17), IpaC interacts with the DPPC membranes in the
absence or presence of added calcium (Table 2). Interestingly,
while the absolute value of the maximum surface pressure
change for the phospholipid monolayers caused by IpaC is
greater in the presence of 10 mM calcium, the ratio of IpaC
penetration at high initial surface pressures relative to that at
low initial surface pressures is greater in the absence of calcium
(Table 2). This indicates that IpaC penetration of phospholipid
membranes, unlike that of factor VII, is not calcium depen-
dent.
Interestingly, when IpaC is freshly diluted from solutions
containing urea, the observed protein-induced surface pres-
sure changes are higher (Table 2). In control experiments, urea
FIG. 1. IpaC penetrates model DPPC membranes. (A) Fibrinogen (used
here as a negative-control protein that does not penetrate phospholipid mem-
branes) was injected into the aqueous subphase of a Langmuir-Blodgett trough
at different initial DPPC pressures (E, 3.0 dynes/cm; h, 4.0 dynes/cm; ‚, 5.6
dynes/cm). No interaction of fibrinogen with the DPPC monolayer is seen once
the initial lipid pressure is 10 dynes/cm or greater (data not shown). (B) IpaC was
injected into the aqueous subphase at different initial DPPC pressures ({, 3.0
dynes/cm; E, 5.0 dynes/cm; h, 10.0 dynes/cm; ‚, 15.0 dynes/cm). In both panels,
single datum points are given at each time; however, the data sets shown are
representative of those generated in at least three independent experiments that
gave nearly identical results. The magnitude of the surface pressure changes at
low initial lipid densities in panel A were greater than the surface pressure
changes caused by IpaC (B) because of the relatively small size of IpaC and the
much lower subphase concentration used for IpaC.
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alone (at concentrations up to 50 mM) did not cause changes
in surface pressure when it was injected beneath compressed
phospholipid monolayers at any initial lipid pressure (data not
shown), indicating that urea in the IpaC samples did not con-
tribute directly to the larger observed surface pressure
changes. From Table 2, it is clear that IpaC interacts more
extensively with phospholipid membranes when it starts out in
a partially unfolded state. This is interesting since, like SipC
from Salmonella (7), IpaC appears to be secreted via a su-
pramolecular “needle complex” that spans the inner and outer
membranes of the pathogen (5). In Salmonella, the needle
complex is proposed to have a relatively narrow inner diameter
(5), indicating that SipC is probably released in a partially
unfolded state. It is anticipated, therefore, that IpaC and SipC
rapidly generate their final tertiary and quaternary structures
at the host-pathogen interface (concomitant with formation of
IpaC [SipC]-containing protein complexes).
De Geyter and coworkers suggest that IpaC possesses mem-
brane-lysing potential based on its ability to release calcein
trapped in vesicles composed of phosphatidylserine (an acidic
phospholipid typically found at the inner face of the cytoplas-
mic membrane) and phosphatidylcholine (a neutral phospho-
lipid) (3). This lytic activity is largely pH dependent, with little
activity seen at neutral pH and with most efficient membrane
lysis occurring below pH 6.0 (3). This is distinct from the
penetration of DPPC membranes at neutral pH as described
here. Moreover, it was shown in previous work that IpaC
enhances the invasive capacity of S. flexneri without lysing host
cells (9) and IpaC does not appear to possess a pH-dependent
hemolytic activity in vitro (data not shown).
Because of the sensitivity of the assay described here for
monitoring protein-membrane interactions under a variety of
conditions, it is now possible to monitor the effect that IpaC
and IpaC-containing protein complexes have on membranes
composed of different phospholipids. This will provide a con-
venient model for deducing the events occurring at the host-
pathogen interface immediately prior to S. flexneri entry into
host cells. It is difficult at this point to determine whether IpaC
penetration of DPPC monolayers is comparable to that of
pore-forming toxins as previously proposed by De Geyter and
coworkers (3); however, it is important to note that IpaC does
not lyse and is not cytotoxic for cultured Henle 407 cells (9;
data not shown). Therefore, if IpaC does form a pore following
interaction with a host cell membrane, this pore does not result
in the rapid death of the host cell. Alternatively, it is possible
that IpaC penetrates phospholipid membranes at neutral pH
but forms a pore only as the pH is lowered to that found in
early endosomal compartments. This would be consistent with
the work reported by De Geyter et al. (3). It should be possible
to determine whether IpaC possesses properties consistent
with pore formation by monitoring protein-protein interac-
tions (see reference 2) involving membrane-imbedded IpaC.
It has been shown that IpaB-IpaC complexes being immu-
noprecipitated onto the surfaces of latex beads is sufficient for
promoting the uptake of these beads by cultured cells, suggest-
ing that both IpaB and IpaC have important roles in cellular
invasion by S. flexneri (10). It is therefore possible that IpaB
influences the action of IpaC at the host-pathogen interface
and that it has a profound effect on IpaC’s ability to interact
with phospholipid membranes. It will be important to compare
the interactions that IpaC has with phospholipid membranes
before and after its recruitment into protein complexes con-
taining IpaB. Because Ipa complexes presumably represent
IpaC in its natural extracellular context, their formation can be
expected to enhance the membrane interactions seen here. It is
also possible that recruitment into Ipa complexes may diminish
IpaC’s interaction with phospholipid membranes while in-
creasing its ability to interact with cellular integrins, which has
been described as being a potential receptor for the Ipa com-
plex by Terajima et al. (18) and Watarai et al. (20). In addition
to using Langmuir films to explore the action of IpaC, it will be
important to explore the same parameters for Salmonella in-
vasion protein C (SipC), which is a putative homologue of
IpaC (7). A comparison of the membrane-penetrating poten-
tials of these two proteins would be enlightening since Salmo-
nella invades epithelial cells in much the same way as S. flex-
neri, but without lysing the resulting membrane-bound vacuole
(7).
Addition of purified IpaC to Henle 407 cells promotes cy-
toskeletal changes. Because IpaC interacts with DPPC mem-
branes and has been shown to promote the uptake of virulence
plasmid-cured S. flexneri when added at high concentrations,
its effect on the cytoskeleton of Henle 407 cells was explored.
Henle 407 cells (ATCC CCL6) were grown in Eagle’s modified
minimal essential medium (MEME; Fisher Scientific) contain-
ing 10% calf serum (Gibco-BRL) and incubated in 5% CO2.
When incubated in 2 mM IpaC in serum-free medium, Henle
407 cells become rounded after 1 h, with some of the cells
detaching after even longer incubations (data not shown). At
no point during exposure to IpaC do the attached cells display
IpaC-related cytotoxicity as monitored by their ability to ex-
clude trypan blue or their failure to release lactate dehydro-
genase into the culture supernatant (data not shown). These
morphological changes suggest that IpaC induces cytoskeletal
rearrangements in Henle 407 cells. To confirm this, Henle 407
TABLE 1. Changes in the surface pressures of DPPC membranes
caused by factor VII and IpaC
Initial lipid pressure
(dynes/cm)
Change in lipid pressure upon







a The data shown are representative results from a series of at least three
independent experiments with similar results (deviation, #10%). Factor VII
requires the presence of 10 mM CaCl2 for significant membrane penetration,
while the results given for IpaC were obtained in the absence of added calcium.
TABLE 2. The effect of urea and calcium on surface pressure





Change in lipid pressure
upon addition of IpaC
(DP)a at an initial lipid
pressure (dynes/cm) of:
Multiple of increase
in lipid pressure at
15 dynes/cm versus
initial lipid pressure
at 3 dynes/cm3 5 10 15
2 2 0.3 1.0 1.4 2.1 7.0
2 1 0.6 1.0 1.7 2.1 3.5
1 2 1.1 1.3 2.4 2.9 2.6
1 1 2.2 2.8 3.4 4.1 1.9
a The data shown are representative results from a series of at least three
independent experiments that generated similar results (deviation, #10%).
b Samples were prepared in 2 M urea as described in the text and rapidly
diluted into 0.1 M Tris (pH 7.4) to promote protein refolding. The final concen-
tration of urea was less than 50 mM following addition to the aqueous subphase
in all cases.
c CaCl2 was added to a final concentration of 10 mM.
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cells were grown on coverslips and incubated with 2 mM IpaC
in serum-free MEME. Actin staining was the carried out by
simultaneously fixing, permeabilizing, and staining the cells for
15 min in a solution containing 3.7% formaldehyde, 1% palmi-
toyl-lysophosphatidylcholine, and rhodamine-phalloidin. The
stained cells were washed with PBS and overlaid with PBS
containing 50% glycerol and 1 mg of n-propylgallate per ml.
Stained actin was viewed by fluorescence microscopy on an
Olympus BX60 microscope equipped with a charge-coupled
device camera (Optronics) and videocapture card (Truevi-
sion).
After a 7-min incubation with IpaC, f-actin appeared to
accumulate at the cell edges with the appearance of numerous
microspikes (Fig. 2). After 30 min, the cells started to show
signs of rounding up while appearing to have less overall f-
actin content relative to that seen at 7 min as judged by a
decrease in overall fluorescence intensity (Fig. 2). These time
points correlate reasonably well with the reported times for
cytoskeletal changes observed during S. flexneri invasion (1). It
was recently reported that IpaC induces actin polymerization
in (i) 3T3 cells permeabilized with saponin, (ii) 3T3 cells mi-
croinjected with IpaC, and (iii) HeLa cells expressing ipaC
(19). In this work, IpaC added to the extracellular environment
elicits a similar effect except that, unlike with permeabilized
cells (19), IpaC does not cause detectable cytotoxic effects (at
low IpaC concentrations) at times exceeding 1 h (data not
shown). This observation suggests that permeabilization intro-
duces cellular changes that ultimately disrupt ongoing func-
tions and that such disruptions do not occur when IpaC is
added to the extracellular milieu.
FIG. 2. Extracellular IpaC promotes cytoskeletal changes in Henle 407 cells. The cells were incubated at 37°C in serum-free MEME and immediately fixed (A) or
fixed after 7 or 30 min in the serum-free MEME (B and C, respectively). Alternatively, the cells were incubated in serum-free MEME containing 2 mM IpaC for 7 min
(D) or 30 min (E) andstained for analysis of polymerized actin by fluorescence microscopy (at a magnification of 3400). 1/8, 1/8-s exposure.
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The ability of IpaC to elicit changes in cultured cells suggests
that it interacts with the host cell surface to trigger a cascade of
events. An earlier study implicated a5b1 integrins as potential
receptors for Ipa protein complexes (20). In previous work
from our laboratory, the need for high IpaC concentrations to
promote overt cellular effects may indicate that there is a large
number of possible IpaC binding sites (9), perhaps because the
IpaC interaction with host cells is rather general. Such an
interaction could be explained if IpaC was able to interact
directly with the host cell membrane in addition to, or instead
of, integrin receptors.
Exogenously added IpaC promotes uptake of a S. flexneri
ipaC mutant. In a recent report, it was shown that expression
of ipaC in HeLa cells leads to a fivefold enhancement in the
uptake of S. flexneri (19). Earlier work showed that exog-
enously added IpaC enhances invasion over fourfold for IpaC
prepared in 20 mM phosphate (pH 7.2) with 150 mM NaCl
(PBS) (9) and eightfold for IpaC prepared in PBS containing
2 M urea (2). Moreover, high concentrations of IpaC promote
the uptake of small numbers of plasmid-cured S. flexneri (9).
To determine the potential importance of IpaC-induced cy-
toskeletal changes and its potential relationship with IpaC-
membrane interactions, the protein was added to Henle 407
cells and the subsequent effect on the uptake of different
strains of S. flexneri was monitored.
S. flexneri 2a strain 2457T was provided by A. T. Maurelli
(Uniformed Services University of the Health Sciences, Be-
thesda, Md.), and S. flexneri strain SF621 (carrying a nonpolar
null mutation in ipaC) (11) was provided by Philippe San-
sonetti (Unité de Pathogénie Microbienne Moléculaire, Insti-
tut Pasteur, Paris, France). S. flexneri entry into Henle 407 cells
was quantified using a gentamicin protection assay as described
previously (9) except that the bacteria were centrifuged onto
the surfaces of the Henle 407 cells to promote efficient contact
between the bacteria and the host cells. S. flexneri strain 2457T
was used at a multiplicity of infection (MOI) of 1.0, while the
noninvasive strains BS103 and SF621 were used at an MOI of
10 or greater. Bacteria were added to the monolayers in serum-
free MEME and incubated for 30 min at 37°C. The monolayers
were then washed with MEME containing 5% newborn calf
serum and 50 mg of gentamicin per ml, rinsed with serum-free
MEME, and overlaid with 0.5% agarose and 0.5% agar con-
taining 23 Luria-Bertani medium. The plates were incubated
overnight at 37°C, and the resulting colonies were counted.
Exogenously added IpaC does not induce uptake of the
plasmid-cured S. flexneri strain BS103 at high nanomolar con-
centrations, even at a high MOI, while purified IpaC does
promote uptake of strain SF621 (data not shown). While an
ipaC null mutant of S. flexneri is noninvasive and avirulent (11),
exogenously added IpaC (50 nM) restores a significant portion
of its invasive capacity (up to 5% of wild-type activity in some
experiments). An important observation here is that because
IpaC is a relatively efficient extracellular effector for the uptake
of SF621 but not for BS103, there is a factor in addition to
IpaC, perhaps IpaB and/or IpaD, that is an important partic-
ipant in the invasion process.
Taken together, the data indicate that purified IpaC pene-
trates model phospholipid membranes, induces cytoskeletal
changes in cultured epithelial cells, and promotes uptake of an
ipaC null mutant of S. flexneri by cultured cells. It is not yet
clear whether penetration of phospholipid membranes by IpaC
is directly related to the observed changes in actin polymeriza-
tion in Henle 407 cells; however, invasion data may support
this possibility. As shown in Table 3, the uptake of wild-type S.
flexneri is enhanced over eightfold by exogenously added IpaC
when the IpaC protein is present in its fully folded state prior
to its addition to the reaction mixture of the modified invasion
assay used here. In contrast, IpaC enhances invasion by wild-
type S. flexneri invasion by nearly 15-fold when it is freshly
refolded from a stock solution containing 2 M urea (Table 3).
These data are consistent with earlier results (2), and they
parallel results from experiments designed to explore IpaC’s
ability to more efficiently penetrate phospholipid membranes
when starting out in a partially folded state (Table 2). There-
fore, it appears likely that there is a correlation between IpaC-
mediated effects on epithelial cells and IpaC-dependent pen-
etration of phospholipid membranes.
The data presented here provide the first evidence that pu-
rified IpaC elicits cytoskeletal changes in cultured cells when it
is presented as part of the extracellular environment. The
ability for IpaC to carry out this activity, and thus its role in
Shigella pathogenesis, may be related to its ability to interact
with and possibly integrate into the cytoplasmic membranes of
host cells. This is a significant observation that should contrib-
ute greatly to our understanding of the events responsible for
the early steps in pathogenesis. Clearly the potential relation-
ship between IpaC-membrane interactions and IpaC-mediated
changes in the cytoskeletons of cultured epithelial cells war-
rants continued investigation.
Interestingly, the invasive phenotype of S. flexneri requires
the properly timed secretion of IpaB and IpaD along with
IpaC. Elimination of the gene encoding any of these proteins
does not prevent secretion of the others (12), but it does
completely eliminate the invasive phenotype (11). The impor-
tance of IpaD has been suggested to be at the level of secretion
(12); however, IpaD has also been described as being part of a
complex that (i) associates with a5b1 integrins (20) and (ii) is
involved in the uptake of noninvasive Escherichia coli (18).
Other evidence suggests that an IpaB-IpaC complex is the
effector of S. flexneri invasion (10), while data from our labo-
ratory and that of others indicate that IpaC alone has a central
role in the entry of S. flexneri into cultured cells (9, 19). In its
soluble form, IpaC exists as part of a complex that involves
both IpaC-IpaC and IpaC-IpaB interactions (2). It is therefore
important to consider the potential effect that IpaB may have
on IpaC’s ability to penetrate the host cell membrane following
the release of both proteins at the host-pathogen interface. As
mentioned previously, IpaB may have a profound influence on
IpaC’s ability to penetrate phospholipid membranes; however,
continuing work will be needed to determine what form these
effects will take. Determining the regions on IpaC that are
TABLE 3. Exogenously added IpaC enhances invasion
by wild-type S. flexneri
S. flexneri strain Form of IpaC addeda Relative invasionb
BS103 None 0
BS103 PBS 0
BS103 PBS 1 2 M urea 0
2457T None 1.00
2457T PBS 8.33
2457T PBS 1 2 M urea 14.81
a IpaC was either prepared in the absence of denaturing agents and was added
from a PBS stock solution or prepared in the presence of urea and dialyzed
against PBS containing 2 M urea prior to being added to the invasion assay. In
all experiments, the final concentration of IpaC was 100 nM and the concentra-
tion of urea never exceeded 40 mM.
b Invasion by wild-type S. flexneri in the absence of added IpaC was 54 colonies
per well and was given the relative value of 1.00. All values are the averages
(615%) of triplicate results, and although values varied slightly from one exper-
iment to the next, these data are representative of at least three independent
experiments.
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important for membrane penetration and those important for
the protein-protein interactions involving IpaC may provide a
great deal of insight into the effects that IpaB may have on the
results presented here. Moreover, the prominent hydrophobic
domains identified on IpaB may indicate that this protein, in
concert with IpaC, has an important role in phagosomal escape
by S. flexneri. This would be consistent with the fact that IpaB
appears to be important for phagosomal escape (6) while pu-
rified IpaB is not hemolytic (14). Such a scenario suggests that
the IpaB-IpaC complex retains the ability to penetrate phos-
pholipid membranes. Indeed, a tremendous amount of work
remains; however, the membrane penetration assay described
here and the protein-protein interactions described in a previ-
ous report from this laboratory (2) should provide pertinent
information on the detailed mechanism of S. flexneri entry into
epithelial cells.
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